Granulocyte-Colony Stimulating Factor for Mobilizing Bone Marrow Stem Cells in Subacute Stroke
Author(s) -
Timothy J. England,
Maryam Abaei,
Dorothee P. Auer,
James Lowe,
David Jones,
Gillian M. Sare,
Marion Walker,
Philip M. Bath
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.636449
Subject(s) - medicine , granulocyte colony stimulating factor , placebo , stroke (engine) , modified rankin scale , cd34 , bone marrow , gastroenterology , lesion , adverse effect , surgery , stem cell , pathology , chemotherapy , ischemia , ischemic stroke , mechanical engineering , alternative medicine , biology , engineering , genetics
Granulocyte-colony stimulating factor (G-CSF) is neuroprotective in experimental stroke and mobilizes CD34(+) peripheral blood stem cells into the circulation. We assessed the safety of G-CSF in recent stroke in a phase IIb single-center randomized, controlled trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom